IDMI
IDM Pharma Inc, is moving higher today after news was released that health authorites in Europe have determined that IDMI's rare bone cancer drug, L-MTPE-PE, suggested a possible benefit in terms of survival and have requested clarification of the existing data.
Penny stock traders have shown an interest in todays' news release and pushed IDMI higher in today's session.
1000 Penny Stocks